BioCentury
ARTICLE | Company News

EnVivo names Dunsire CEO

July 11, 2013 11:52 PM UTC

EnVivo Pharmaceuticals Inc. (Watertown, Mass.) hired Deborah Dunsire as president, CEO and a director, effective mid-August. Dunsire retired as president and CEO of the Millennium Pharmaceuticals Inc. subsidiary of Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) in June. She replaces interim EnVivo CEO Robert Weisskoff -- a partner at the company's sole investor Fidelity Biosciences -- who will return to his role as a member of EnVivo's board. ...